Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Kyverna Therapeutics, Inc. | 10%+ Owner | Common Stock | 736K | Feb 12, 2024 | Indirect | ||
Kyverna Therapeutics, Inc. | 10%+ Owner | Series A-1 Redeemable Convertible Preferred Stock | 0 | Feb 12, 2024 | Indirect | ||
Kyverna Therapeutics, Inc. | 10%+ Owner | Series A-2 Redeemable Convertible Preferred Stock | 0 | Feb 12, 2024 | Indirect | ||
Kyverna Therapeutics, Inc. | 10%+ Owner | Series B Redeemable Convertible Preferred Stock | 0 | Feb 12, 2024 | Indirect |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
KYTX | Kyverna Therapeutics, Inc. | Feb 12, 2024 | 6 | $0 | 4 | Feb 14, 2024 | 10%+ Owner |
KYTX | Kyverna Therapeutics, Inc. | Feb 7, 2024 | 0 | $0 | 3 | Feb 7, 2024 | 10%+ Owner |